Jared Holz, Mizuho healthcare strategist, joins ‘Squawk on the Street’ to discuss whether the conversation around healthcare will change much relative to last year, whether M&A will be a part of the playbook for Merck and Biogen, and the prospect for weight-loss drugs this year.